BTIG initiated coverage of Novavax (NVAX) with a Buy rating and $19 price target The company’s standalone COVID vaccine seems to be a ...

The S&P 500 may be due for a short-term bounce after its pullback from last week's record highs — but don't expect it to last ...

BTIG analyst David Larsen lowered the firm’s price target on Health Catalyst (HCAT) to $10 from $13 and keeps a Buy rating on the shares after ...

Flywire (NASDAQ:FLYW – Get Free Report) was downgraded by equities research analysts at BTIG Research from a “buy” rating to ...

BTIG downgraded General Dynamics Corporation (NYSE:GD)to Neutral given the ongoing regulatory hurdles and supply chain ...

Despite the unexpected move, analysts from BTIG consider the purchase a low-risk investment given the relatively small cash outlay. The acquisition is seen as an opportunity for Globus Medical to ...

The S&P 500's latest sell-off took it back to its February lows of 5923, notes Jonathan Krinsky, BTIG's technical guru. That's left it in danger of breaking below the uptrend from last summer's low.

Investing.com -- BTIG upgraded Snowflake Inc (NYSE:SNOW) to "Buy" from "Neutral" and introduced a $220 price target on improving demand trends and potential AI-driven growth. The brokerage noted ...

As of December 23, 2024, the average one-year price target for ImmunityBio is $14.54/share. The forecasts range from a low of $4.80 to a high of $31.50. The average price target represents an ...

For more information about the conference, email uscorporateaccess@btig.com. Please note that participants must be pre-registered to attend. To access BTIG insights, contact a BTIG representative ...

January 28, 2025--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the BTIG Annual ...

Investing.com -- BTIG upgraded Snowflake Inc (NYSE:SNOW) to "Buy" from "Neutral" and introduced a $220 price target on improving demand trends and potential AI-driven growth. The brokerage noted that ...